Analysts Set Phibro Animal Health Corporation (NASDAQ:PAHC) PT at $20.80

Phibro Animal Health Corporation (NASDAQ:PAHC) has been given a consensus recommendation of “Reduce” by the six brokerages that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $20.80.

Several research analysts have recently issued reports on PAHC shares. BNP Paribas Exane raised Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 target price for the company in a research report on Monday. Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. BNP Paribas raised Phibro Animal Health to a “hold” rating in a research report on Monday. Finally, Morgan Stanley raised their price objective on Phibro Animal Health from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, May 8th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Phibro Animal Health during the 4th quarter valued at $29,000. National Bank of Canada FI purchased a new stake in Phibro Animal Health during the 1st quarter valued at $30,000. Lazard Asset Management LLC boosted its stake in Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after purchasing an additional 1,589 shares during the last quarter. Aquatic Capital Management LLC purchased a new stake in Phibro Animal Health during the 4th quarter valued at $69,000. Finally, Virtus Fund Advisers LLC purchased a new stake in Phibro Animal Health during the 4th quarter valued at $69,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Trading Down 2.0%

PAHC opened at $23.96 on Monday. The business has a 50 day simple moving average of $21.49 and a two-hundred day simple moving average of $21.91. The firm has a market capitalization of $971.10 million, a price-to-earnings ratio of 30.72, a PEG ratio of 0.46 and a beta of 0.74. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. Phibro Animal Health has a one year low of $16.16 and a one year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. The firm had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. Analysts predict that Phibro Animal Health will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.